Press Release Late HIV Vaccine Boost Elicits Higher Immune Response in Volunteers from the RV144 Thai Trial Jun 20, 2017 Late HIV Vaccine Boost Elicits Higher Immune Response in Volunteers from the RV144 Thai Trial. New study evaluates effects of boost given to volunteers 6-8 years after their initial vaccination in the RV144 HIV vaccine trial. News Dual-use Heroin Vaccine Elicits Immune Response in Mice May 3, 2017 News Dr. Carl Alving Inducted as National Academy of Inventors Fellow Apr 21, 2017 News Clinical Training Course in Liberia Boosts Biopreparedness Efforts in West Africa Mar 30, 2017 Joint West Africa Research Group helps ensure the region is prepared for the next infectious disease outbreak News World TB Day: MHRP Research Physician Focuses on Problem of TB/HIV Co-infection Mar 24, 2017 News New Multi-site Phase 2 Ebola Vaccine Study Begins in Africa Mar 23, 2017 Study will evaluate a prime-boost Ebola vaccine regimen in both healthy and HIV-infected volunteers Pagination First page « First Previous page ‹ Previous … Page 20 Page 21 Current page 22 Page 23 Page 24 … Next page Next › Last page Last »
Press Release Late HIV Vaccine Boost Elicits Higher Immune Response in Volunteers from the RV144 Thai Trial Jun 20, 2017 Late HIV Vaccine Boost Elicits Higher Immune Response in Volunteers from the RV144 Thai Trial. New study evaluates effects of boost given to volunteers 6-8 years after their initial vaccination in the RV144 HIV vaccine trial.
News Clinical Training Course in Liberia Boosts Biopreparedness Efforts in West Africa Mar 30, 2017 Joint West Africa Research Group helps ensure the region is prepared for the next infectious disease outbreak
News New Multi-site Phase 2 Ebola Vaccine Study Begins in Africa Mar 23, 2017 Study will evaluate a prime-boost Ebola vaccine regimen in both healthy and HIV-infected volunteers
